-
Signature
-
Matt Benson, Attorney-in-Fact for Troy Rudd
-
Issuer symbol
-
ACM
-
Transactions as of
-
15 Aug 2025
-
Transactions value $
-
-$4,292,278
-
Form type
-
4
-
Filing time
-
18 Aug 2025, 16:03:04 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Rudd Troy |
CHIEF EXECUTIVE OFFICER, Director |
C/O AECOM, 13355 NOEL RD, SUITE 400, DALLAS |
Matt Benson, Attorney-in-Fact for Troy Rudd |
18 Aug 2025 |
0001653811 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ACM |
Common Stock |
Options Exercise |
$2.06M |
+53.1K |
|
$38.72 |
53.1K |
15 Aug 2025 |
Direct |
F1 |
| transaction |
ACM |
Common Stock |
Sale |
-$5.01M |
-42K |
-79.09% |
$119.41 |
11.1K |
15 Aug 2025 |
Direct |
F2 |
| transaction |
ACM |
Common Stock |
Sale |
-$1.33M |
-11.1K |
-100% |
$120.12 |
0 |
15 Aug 2025 |
Direct |
F3 |
| holding |
ACM |
Common Stock |
|
|
|
|
|
275K |
15 Aug 2025 |
by TN Rudd Investments, LP |
|
| holding |
ACM |
Common Stock |
|
|
|
|
|
1.4K |
15 Aug 2025 |
by Merrill Lynch under AECOM Retirement & Savings Plan (RSP) |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ACM |
Employee Stock Option |
Options Exercise |
$0 |
-53.1K |
-100% |
$0.00 |
0 |
15 Aug 2025 |
Common Stock |
53.1K |
$38.72 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: